NASDAQ:CSBR

Champions Oncology Stock Insider Trading

etoro logo Buy CSBR
*Your capital is at risk
$5.69
-0.0350 (-0.611%)
At Close: Jun 03, 2026

Champions Oncology Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 2.8M and sold 8.3K CSBR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 2.8M shares
Sell 8.3K shares
98% Buy Activity
Weak Negative Correlation
Buy Signal High Confidence
May 26, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 100.
  • Confidence increased due to high data reliability score of 90.
  • Supported by overwhelming buy-side pressure (98% buys).

Historical Insider Trades

Date Type Person Role Amount
Nov 05, 2025
Buy
Option to purchase Common Stock
A-Award
Tobin Scott R
Director 25 460
Value: $173.1K
Nov 05, 2025
Buy
Option to purchase Common Stock
A-Award
Mendelson Daniel Newman
Director
Director 13 790
Value: $93.8K
Nov 05, 2025
Buy
Option to purchase Common Stock
A-Award
Sidransky David
Director
Director 21 216
Value: $144.3K
Nov 05, 2025
Buy
Option to purchase Common Stock
A-Award
Breitfeld Philip P.
Director
Director 13 790
Value: $93.8K
Nov 05, 2025
Buy
Option to purchase Common Stock
A-Award
Ackerman Joel
Director
Director 21 216
Value: $144.3K
Oct 30, 2025
Buy
Option to purchase Common Stock
M-Exempt
Ackerman Joel
Director
Director 94 405
Value: $198.3K
Oct 30, 2025
Buy
Common Stock
M-Exempt
Ackerman Joel
Director
Director 94 405
Value: $198.3K
Jul 16, 2025
Buy
Option to purchase Common Stock
A-Award
Brainin Robert Lawrence
CEO
CEO / President 225 000
Value: $1.76M
Jul 16, 2025
Buy
Option to purchase Common Stock
A-Award
Brainin Robert Lawrence
CEO
CEO / President 62 500
Value: $487.5K
Jul 16, 2025
Buy
Option to purchase Common Stock
A-Award
Brainin Robert Lawrence
CEO
CEO / President 62 500
Value: $487.5K
Jul 16, 2025
Buy
Option to purchase Common Stock
A-Award
Brainin Robert Lawrence
CEO
CEO / President 100 000
Value: $780.0K
Jul 16, 2025
Buy
Option to purchase Common Stock
A-Award
Brainin Robert Lawrence
CEO
CEO / President 100 000
Value: $780.0K
Jul 16, 2025
Buy
Option to purchase Common Stock
A-Award
Brainin Robert Lawrence
CEO
CEO / President 150 000
Value: $1.17M
Mar 25, 2025
Sell
Common Stock
J-Other
Breitfeld Philip P.
Director
Director 4 150
Value: $0
Mar 25, 2025
Sell
Common Stock
J-Other
Breitfeld Philip P.
Director
Director 4 150
Value: $0
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Brainin Robert Lawrence
Director
Director 23 030
Value: $106.9K
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Breitfeld Philip P.
Director
Director 18 715
Value: $86.8K
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Sidransky David
Director
Director 21 880
Value: $101.5K
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Mendelson Daniel Newman
Director
Director 21 590
Value: $100.2K
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Tobin Scott R
Director 34 550
Value: $160.3K
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Ackerman Joel
Director
Director 43 190
Value: $200.4K
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Ackerman Joel
Director
Director 43 190
Value: $200.4K
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Tobin Scott R
Director 34 550
Value: $160.3K
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Mendelson Daniel Newman
Director
Director 21 590
Value: $100.2K
Nov 12, 2024
Buy
Option to purchase Common Stock
A-Award
Sidransky David
Director
Director 21 880
Value: $101.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CHAMPIONS ONCOLOGY
Champions Oncology
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides Personalized cancer care based upon the implantation of human tumors in immune...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE